Results 51 to 60 of about 13,027 (197)

Dosage of botulinum toxin in patients undergoing treatment for hemifacial spasm: is there modification during follow-up?

Arquivos de Neuro-Psiquiatria
Background The movement disorder known as hemifacial spasm is characterized by involuntary contractions of the muscles that are innervated by the facial nerve. The treatment of choice for this condition is botulinum toxin injections.
Fátima de Menezes Dantas, Felipe Olobardi Freire, Agábio Diógenes Pessoa Neto, Clécio de Oliveira Godeiro Júnior, Rodrigo Alencar e Silva   +4 more
doaj   +1 more source

Uso da toxina botulínica no controle do bruxismo [PDF]

, 2014
TCC (graduação) - Universidade Federal de Santa Catarina. Centro de Ciências da Saúde. Odontologia.A toxina botulínica é uma substância produzida pela bactéria Clostridium botulinum, e o seu uso oferece ao cirurgião dentista uma nova alternativa para ...
Francescon, Ariane
core  

Incidences of Mould and Bacterial Toxins in Dairy Products [PDF]

, 2016
This chapter reviews the common bacterial toxins and mycotoxins involved in food poisoning in milk and dairy products. Food-borne bacterial infection occurs when food contaminated with pathogenic bacteria is consumed. The major type of diseases caused by
El-Nezamy, HS, Wan, MLY, N.P. Shah, M.L.Y. Wan, H.I. El-Nezami, Shah, NP   +5 more
core   +1 more source

Novel Botulinum Neurotoxins: Exploring Underneath the Iceberg Tip

Toxins, 2018
Botulinum neurotoxins (BoNTs), the etiological agents of botulism, are the deadliest toxins known to humans. Yet, thanks to their biological and toxicological features, BoNTs have become sophisticated tools to study neuronal physiology and valuable ...
Domenico Azarnia Tehran, Marco Pirazzini
doaj   +1 more source

Molecular Diversity of BoNT-Producing Clostridia—A Still-Emerging and Challenging Problem

Diversity, 2023
The diversity of BoNT-producing Clostridia is still a worrying problem for specialists who explore the evolutionary and taxonomic diversity of C. botulinum.
Tomasz Grenda, Aleksandra Jarosz, Magdalena Sapała, Karol Stasiak, Anna Grenda, Piotr Domaradzki, Krzysztof Kwiatek   +6 more
doaj   +1 more source

Designed Azolopyridinium Salts Block Protective Antigen Pores In Vitro and Protect Cells from Anthrax Toxin [PDF]

, 2013
Background:Several intracellular acting bacterial protein toxins of the AB-type, which are known to enter cells by endocytosis, are shown to produce channels.
Barth, Holger, Anika Bronnhuber, Benz, Roland, Hajós György, Markus Huber-Lang, Hajós, György, Kerstin Duscha, Riedl Zsuzsanna, Beitzinger, Christoph, Riedl, Zsuzsanna, Duscha Kerstin, György Hajós, Huber-Lang Markus, Beitzinger Christoph, Barth Holger, Duscha, Kerstin, Bronnhuber, Annika, Benz Roland, Christoph Beitzinger, Roland Benz, Holger Barth, Bronnhuber Anika, Bronnhuber, Anika, Huber-Lang, Markus, Zsuzsanna Riedl   +24 more
core   +1 more source

Botulinum toxin in ophthalmic plastic surgery

Indian Journal of Ophthalmology, 2005
Botulinum toxin chemodenervation has evolved greatly over the past 30 years since its introduction in the 1970s for the management of strabismus. Among ophthalmic plastic surgeons, botulinum toxins are often used as the first line treatment for facial ...
Naik Milind, Soparkar Charles, Murthy R, Honavar S   +3 more
doaj  

Capsaicin protects neuromuscular junctions from the inhibitory effects of botulinum neurotoxin A [PDF]

, 2008
Within 24 hrs after injecting botulinum neurotoxin A (BoNT/A) into the hindlimb, mice lost the toe spread reflex and developed progressive muscle weakness. At the same time, the compound muscle action potential amplitude decreased. Injection of capsaicin
Carmen Garcia, Joseph McArdle, Kormakur Hognason, Joseph Potian, Baskaran Thyagarajan, Natalia Krivitskaya   +5 more
core   +1 more source

Structural analysis of botulinum neurotoxins type B and E by Cryo-EM [Elektronisk resurs] [PDF]

, 2022
Botulinum neurotoxins (BoNTs) are the causative agents of a potentially lethal paralytic disease targeting cholinergic nerve terminals. Multiple BoNT serotypes exist, with types A, B and E being the main cause of human botulism.
Masuyer, Geoffrey,, Martínez-Carranza, Markel,, Stenmark, Pål,, Košenina, Sara,, Davies, Jonathan R.,, Lund University.   +5 more
core   +1 more source

BOTULINUM TOXIN IN OPHTHALMOLOGY [PDF]

Australian and New Zealand Journal of Ophthalmology, 1988
AbstractAlan B. Scott selected, researched and developed Type A Botulinum toxin for clinical use in ophthalmology. This unique drug has proved invaluable for treatment of a number of conditions which are difficult to treat in ophthalmology and in a variety of other disciplines.
D, Dunlop, G, Pittar, C, Dunlop
openaire   +2 more sources